(Q37427388)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19333228%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

review article

1 reference

title

Hypothyroidism related to tyrosine kinase inhibitors: an emerging toxic effect of targeted therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19333228%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19333228%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

author name string

Francesco Torino

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19333228%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Salvatore Maria Corsello

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19333228%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Raffaele Longo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19333228%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Giampietro Gasparini

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19333228%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

language of work or name

English

0 references

publication date

1 April 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19333228%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Clinical Oncology

25 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19333228%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19333228%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19333228%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

page(s)

219-228

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19333228%20AND%20SRC:MED&resulttype=core&format=json

Mechanisms of cutaneous toxicities to EGFR inhibitors.

25 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.4

Rapid progression from subclinical to symptomatic overt hypothyroidism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.4

Long-term toxicity of chemotherapy for testicular cancer--the cost of cure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.4

Thyroid abnormalities after therapeutic external radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.4

Hypothyroidism after sunitinib treatment for patients with gastrointestinal stromal tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.4

Serum thyroid-stimulating hormone measurement for assessment of thyroid function and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.4

The incidence of thyroid disorders in the community: a twenty‐year follow‐up of the Whickham Survey

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.4

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.4

Prevalence and follow-up of abnormal thyrotrophin (TSH) concentrations in the elderly in the United Kingdom

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.4

Hypothyroidism in the elderly

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.4

Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.4

Cyclical combination chemotherapy and thyroid function in patients with advanced Hodgkin's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.4

The clinical and physiological spectrum of interferon-alpha induced thyroiditis: toward a new classification

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.4

Hypothyroidism after treatment with interleukin-2 and lymphokine-activated killer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.4

Autoimmunity resulting from cytokine treatment predicts long-term survival in patients with metastatic renal cell cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.4

Hypothyroidism during immunotherapy with interleukin-2 is associated with antithyroid antibodies and response to treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.4

Hypothyroidism in patients with multiple myeloma following treatment with thalidomide

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.4

Transient thyroiditis after treatment with lenalidomide in a patient with metastatic renal cell carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.4

Central hypothyroidism associated with retinoid X receptor-selective ligands

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.4

The development of Graves' disease following radiation therapy in Hodgkin's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.4

Imatinib induces hypothyroidism in patients receiving levothyroxine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.4

Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.4

Sunitinib induces hypothyroidism in advanced cancer patients and may inhibit thyroid peroxidase activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.4

Tyrosine kinase inhibitors causing hypothyroidism in a patient on levothyroxine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.4

Re: Hypothyroidism in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.4

A Novel Tyrosine-Kinase Selective Inhibitor, Sunitinib, Induces Transient Hypothyroidism by Blocking Iodine Uptake

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.4

Thyroid function test abnormalities in patients with metastatic renal cell carcinoma treated with sorafenib

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.4

The effect of hepatic enzyme-inducing drugs on thyroid hormones and the thyroid gland

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.4

Drugs and thyroid function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.4

Effects of 5,5'-diphenylhydantoin on the metabolic pathway of thyroid hormone in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.4

Changes in thyroid function tests induced by 2 month carbamazepine treatment in L-thyroxine-substituted hypothyroid children

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.4

Rifampin-induced hypothyroidism in patients with Hashimoto's thyroiditis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.4

Presence and possible role of vascular endothelial growth factor in thyroid cell growth and function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.4

Phase I safety and pharmacokinetic study of recombinant human anti-vascular endothelial growth factor in patients with advanced cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.4

Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: continued experience of a phase I trial in rectal cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.4

Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.4

Thyrotoxicosis during sunitinib treatment for renal cell carcinoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.4

Expression of the ret proto-oncogene product in human normal and neoplastic tissues of neural crest origin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.4

Is BRAF the Achilles' Heel of Thyroid Cancer?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.4

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.4

Sorafenib in advanced clear-cell renal-cell carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.4

Sorafenib with interferon alfa-2b as first-line treatment of advanced renal carcinoma: a phase II study of the Southwest Oncology Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.4

Re: Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.4

Cell-surface receptor for thyroid hormone and tumor cell proliferation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.4

Subclinical thyroid disease: scientific review and guidelines for diagnosis and management

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.4

Unanswered questions regarding the management of sunitinib-induced hypothyroidism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.4

Cellular changes in normal blood capillaries undergoing regression after inhibition of VEGF signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.4

VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.4

Terminal ballistics of kinase inhibitors: there are no magic bullets

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.4

Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population: implications for the prevalence of subclinical hypothyroidism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.4

Early cellular abnormalities induced by RET/PTC1 oncogene in thyroid-targeted transgenic mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.4

Thyroid dysfunction in 281 patients with metastatic melanoma or renal carcinoma treated with interleukin-2 alone

31 March 2020

1 reference

12 December 2020

Severe hypothyroidism after thalidomide treatment.

1 reference

12 December 2020

Cloning and expression of the ret proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains

1 reference

12 December 2020

The endocrine effects of nonhormonal antineoplastic therapy

1 reference

12 December 2020

Endocrine effects of cytokines

1 reference

12 December 2020

In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationship.

1 reference

12 December 2020

Hyperthyroidism with low radioiodine uptake after head and neck irradiation for Hodgkin's disease

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRCLINONC.2009.4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19333228%20AND%20SRC:MED&resulttype=core&format=json

release_es3nk7ztbnhljg6pu7pen6nr3y

25 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/es3nk7ztbnhljg6pu7pen6nr3y

24 November 2022

mapped directly with Wikidata item

1 reference